Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
OTC hand cream alleviates eczema
An over-the-counter moisturizing hand cream safely and effectively improved eczema symptoms and lesions, according to research presented at the American Academy of Dermatology Annual Meeting.
Secukinumab demonstrates long-term safety, efficacy for treatment of psoriasis
Secukinumab provided high levels of skin clearance and improved quality of life over 5 years in patients with moderate to severe psoriasis, according to findings presented at the American Academy of Dermatology Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
ED visits for eczema common, costly
In the United States, ED visits for eczema are common, seem to be rising and contribute to a substantial cost-burden, according to findings presented at the American Academy of Dermatology Annual Meeting.
South Beach Symposium highlights ‘cutting edge’ advancements in dermatology, aesthetics
March 1 through 4, the 16th annual South Beach Symposium will offer “cutting edge” education to attendees on the latest treatments, technologies and procedures in clinical and aesthetic dermatology, pediatric dermatology and practice management topics, according to a press release.
Patients with PsA, psoriasis undertreated for CVD risk factors
A large number of patients with psoriatic arthritis and psoriasis are underdiagnosed and go without necessary treatment for hypertension and dyslipidemia, according to findings published in the Journal of Rheumatology.
Ceramide-infused skin barrier reduces costs, complications in ostomy care
Using an ostomy skin barrier infused with ceramide resulted in lower costs and improved satisfaction for patients, according to a study published in the Journal of Wound, Continence and Ostomy Nursing.
RAPID3 index fails to assess mental health for psoriatic disease
The Routine Assessment of Patient Index Data 3 for rheumatoid arthritis cannot be used in patients with psoriasis and psoriatic arthritis as it fails to account for potentially significant mental health considerations, according to findings published in the Journal of Clinical Rheumatology.
Patients with psoriasis more likely to experience GI symptoms
Patients with psoriasis are more likely to experience painful gastrointestinal symptoms, according to new research presented at the Crohn’s & Colitis Congress.
FDA accepts application for new Humira biosimilar
Sandoz announced that the FDA has accepted a biologics license application for a proposed biosimilar of the anti-inflammatory drug adalimumab, known commercially as Humira.
Consensus treatment plans streamline therapy, outcomes for pediatric rheumatic diseases
Consensus treatment plans can help reduce variation in treatment approaches, identify effective treatment strategies and standardize outcomes for pediatric patients with rheumatic diseases, according to a recent review published in Arthritis & Rheumatology.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read